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TET family enzymes convert 5-methylcytosine (5mC)
to 5-hydroxymethylcytosine (5hmC) in DNA. Here, we
show that Tet1 and Tet2 are Oct4-regulated enzymes
that together sustain 5hmC in mouse embryonic
stem cells (ESCs) and are induced concomitantly
with 5hmC during reprogramming of fibroblasts to
induced pluripotent stem cells. ESCs depleted of
Tet1 by RNAi show diminished expression of the
Nodal antagonist Lefty1 and display hyperactive
Nodal signaling and skewed differentiation into the
endoderm-mesoderm lineage in embryoid bodies
in vitro. In Fgf4- and heparin-supplemented culture
conditions, Tet1-depleted ESCs activate the tropho-
blast stemcell lineage determinant Elf5 and can colo-
nize the placenta in midgestation embryo chimeras.
Consistent with these findings, Tet1-depleted
ESCs form aggressive hemorrhagic teratomas with
increased endoderm, reduced neuroectoderm, and
ectopic appearance of trophoblastic giant cells.
Thus, 5hmC is an epigenetic modification associated
with the pluripotent state, and Tet1 functions to regu-
late the lineage differentiation potential of ESCs.
INTRODUCTION
The methylation status of DNA influences many biological
processes during mammalian development and is known to be
highly aberrant in cancer (Gal-Yam et al., 2008; Ooi et al.,200 Cell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc.2009). DNA methylation is a powerful mechanism of genome
defense against transposons and other parasitic DNA (Goll and
Bestor, 2005); in addition, promoter methylation in mammals
has long been considered suppressive for gene expression
(Klose and Bird, 2006). Recent whole-genome analyses have
provided insights into the complexity of methylation patterns in
plant and animal species (Farthing et al., 2008; Feng et al.,
2010a; Lister et al., 2009; Meissner et al., 2008; Zemach et al.,
2010). DNA methylation occurs primarily at CpG dinucleotides
in mammals: CpGmethylation marks that are lost on newly repli-
cated DNA strands are faithfully restored by the maintenance
DNA methyltransferase Dnmt1. In embryonic stem cells
(ESCs), however, a substantial fraction of cytosine methylation
occurs in non-CpG contexts, where it has been attributed to
the activity of the de novo methyltransferases Dnmt3a and
Dnmt3b (Lister et al., 2009; Ramsahoye et al., 2000).
Dynamic changes in DNA methylation occur during early
embryogenesis (reviewed in Feng et al., 2010b). Shortly after
fertilization, the paternal genome loses the methylcytosine
mark prior to DNA replication, whereas the maternal genome
loses the mark passively in early cell cycles before blastulation.
De novomethylation by Dnmt3 occurs around the time of blasto-
cyst implantation, to a greater extent in the inner cell mass (ICM),
which remains pluripotent and gives rise to all cell types of the
embryo proper, than in the outer trophectoderm (TE) layer, which
is restricted to an extraembryonic fate and gives rise to the
placenta (Reik et al., 2001). During the formation of primordial
germ cells in the mouse, a second wave of genome-wide deme-
thylation occurs during which imprinted marks are erased; they
are subsequently reset in the developing gametes through de
novo DNA methylation. The tight regulation of DNA methylation
and demethylation is developmentally of crucial importance
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and embryos lose lineage restriction and show transdifferentia-
tion to the extraembryonic trophoblast lineage (Jackson et al.,
2004; Ng et al., 2008).
We recently identified the TET proteins TET1, TET2, and TET3
as a new family of enzymes that alter the methylation status of
DNA (Iyer et al., 2009; Tahiliani et al., 2009). TET proteins are
2-oxoglutarate (2OG)- and Fe(II)-dependent dioxygenases that
catalyze the hydroxylation of 5-methylcytosine to 5-hydroxyme-
thylcytosine (5hmC) in DNA. TET proteins and 5hmC have been
reported in many different tissues, and both 5hmC and Tet
expression/activity are tightly regulated during ESC differentia-
tion (Ito et al., 2010; Ko et al., 2010; Kriaucionis and Heintz,
2009; Szwagierczak et al., 2010; Tahiliani et al., 2009). TET1
and TET2 are both implicated in cancer: TET1 is an MLL partner
in rare cases of acute myeloid (AML) and lymphoid (ALL) leuke-
mias, and loss-of-function of TET2 is strongly associated with
AML as well as a variety of myelodysplastic syndromes and
myeloproliferative disorders (see references in Ko et al.,
2010). Together, these data suggest that dysregulation of
DNA methylation via TET proteins and hmC may have a role
in ESC pluripotency, oncogenic transformation (especially of
hematopoietic stem cells toward the myeloid lineage), and
neuronal function.
Here, we describe the function of Tet proteins (and, by infer-
ence, 5hmC) in mouse ESCs. ESC lines are culture explants
from the inner cell mass (ICM) of the developing blastocyst.
They can bemaintained in the proliferative, undifferentiated state
in culture by using the cytokine leukemia inhibitory factor (LIF) to
activate STAT3 and the serum component bone morphogenetic
protein (BMP) to induce inhibitor-of-differentiation proteins.
When given the appropriate cellular signals, they can differen-
tiate into cellular derivatives of the three primary germ layers:
ectoderm, mesoderm, and endoderm. Withdrawal of LIF from
serum-containing media allows BMP to switch from supporting
self-renewal to inducing mesodermal and endodermal differenti-
ation while blocking entry into neural lineages; when grown in the
absence of both LIF signals and serum, ESCs are predisposed to
convert to a neuronal fate (Ying et al., 2003a, 2003b). These
features of self-renewal and ability to differentiate, characteristic
of a pluripotent state, require a high degree of epigenetic plas-
ticity. Genes crucial for pluripotency are kept active by a self-
organizing network of transcription factors and are rapidly
silenced by histone modifications and DNA methylation during
differentiation, whereas genes that are required later in cellular
differentiation are held in a transiently repressed state by chro-
matin modifications that are easily reversed. Because Tet
proteins modify DNA methylation status, it was conceivable
that they might influence the expression and functions of either
or both classes of genes.
RESULTS
Tet1 and Tet2 Regulate 5hmC Levels in Mouse ESCs
and Are Associated with the Pluripotent State
In culture conditions containing LIF and serum, Tet1 transcripts
are present at high copy numbers in mouse ESCs, comparable
to those of the pluripotency factor Oct4; Tet2 transcripts are
about 5-fold less abundant than Tet1 but still well expressed;Cand Tet3 transcript levels are very low (Figure 1A). Individual
depletion of Tet1 or Tet2 mRNAs with SMARTpool siRNA
duplexes (Figure S1A available online) resulted in a moderate
decrease in 5hmC, whereas combined depletion of both
enzymes reduced 5hmC levels by 75%–80% (Figures 1B and
1C; Figures S1B and S1C). Thus, Tet1 and Tet2 together are
responsible for the bulk of 5hmC production in mouse ESCs
cultured in the presence of LIF. In contrast to a previous report
(Ito et al., 2010), we did not observe major changes in ESC
morphology upon siRNA-mediated depletion of either Tet1 alone
or both Tet1 and Tet2 (Figure S1D).
When plated on gelatin in the presence of LIF, ESCs largely re-
tained expression of Tet1, Tet2, andOct4 over 4 to 5 days.Within
3 days of LIF withdrawal, Tet1 and Tet2mRNA levels declined to
25%–30% of starting levels, with a time course that paralleled
the decline of Oct4mRNA (Figure 1D), and differentiated epithe-
lial-like cells were observed in 4 to 5 days. When the ESCs were
treated with retinoic acid (RA; a potent stimulus for cellular differ-
entiation) at the same time that LIF was withdrawn, Tet1, and
Oct4 expression declined more rapidly (Figure 1D), and epithe-
lial-like morphology was apparent earlier, by day 3. Tet3 mRNA
levels increased more than 10-fold under these conditions (Fig-
ure 1D). Under both conditions, 5hmC levels declined signifi-
cantly, to 40%–60% of control (Tahiliani et al., 2009; Figure 1E);
the moderate change (compared to that seen in Figures 1B and
1C) likely reflects both the incomplete loss of Tet1 and Tet2
under conditions of LIF withdrawal and the upregulation of
Tet3 in response to RA (Figure 1D).
We examined Tet expression and activity during reprogram-
ming of mouse embryonic fibroblasts (MEFs) into induced
pluripotent stem cells (iPSCs) by transduction with the four re-
programming transcription factors Oct4, Sox2, Klf4, and c-Myc
(Takahashi and Yamanaka, 2006). The starting population of
fibroblasts expressed almost no Tet1 mRNA and only a basal
level of Tet2 mRNA, but fully reprogrammed iPSCs that had re-
activated an endogenous Oct4-GFP reporter (Yeom et al.,
1996) displayed levels of Tet1 and Tet2 mRNA comparable to
those in ESCs; Tet3 transcripts also decreased, approaching
the low level observed in ESCs (Figure 1F). In parallel, 5hmC
levels increased, both globally and at MspI sites, from almost
undetectable in fibroblasts to levels typical of ESCs in iPSCs
(Figure 1G). Similar results were obtained during reprogramming
of mouse adult tail-tip fibroblasts into iPSCs (data not shown).
Collectively, these data point to a strong association of Tet1,
Tet2, and 5hmC with the pluripotent state in both ESCs and
iPSCs and a contrasting association of Tet3 with the differenti-
ated state.
Oct4 Regulates TetmRNA Levels
We measured Tet mRNA levels during ESC differentiation
induced by RNAi-mediated depletion of the key pluripotency
factors Oct4, Sox2, and Nanog. ESCs treated with SMARTpool
siRNA duplexes targeting Oct4 differentiated rapidly within
3 days. Differentiation induced by Sox2 RNAi was slower,
requiring 5 days, but alkaline phosphatase-positive colonies
were still present in ESCs treated with Nanog RNAi for 5 days
(Figure S2A). We confirmed that each SMARTpool depleted
expression of its target pluripotency factor (Figure S2B),
although as expected, depletion of each pluripotency factor inell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc. 201
ES cells            HEK
0 1 2 3 4
0.00
0.25
0.50
0.75
1.00
1.25
+ LIF
− LIF
− LIF + RA
0 1 2 3 4
0.00
0.25
0.50
0.75
1.00
1.25
+ LIF
− LIF
− LIF + RA
0 1 2 3 4
0.00
0.25
0.50
0.75
1.00
1.25
+ LIF
− LIF
− LIF + RA
0 1 2 3 4
0
5
10
15
+ LIF
− LIF
− LIF + RA
R
e
l
a
t
i
v
e
 m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
Oct4
Tet1
Tet2
Tet3
Day
A B C
D
E
F
G
T
r
a
n
s
c
r
i
p
t
 
c
o
p
i
e
s
x
1
0
-
3
/
n
g
 
t
o
t
a
l
 
R
N
A
0
5
10
15
qRT-PCR
qRT-PCR
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
MEF       iPS MEF     iPS MEF      iPS
Tet1 Tet2 Tet3
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0
2
4
6
8
10
qRT-PCR
dot blot
R
e
l
a
t
i
v
e
 
5
h
m
C
 
l
e
v
e
l
0.0
0.2
0.4
0.6
0.8
1.0
1.2
MEF  iPS
P < 0.0001
TLC
5
h
m
C
/
t
o
t
a
l
C
 
(
%
)
C         T1        T2      T1+T2siRNA:
0
2
4
6 ***
***
***
anti-5hmC dot blot
R
e
l
a
t
i
v
e
 
5
h
m
C
 
l
e
v
e
l
siRNA:
C     T1    T2    T1
+T2
CD    −
0.0
0.2
0.4
0.6
0.8
1.0
6
7
8
***
***
*
0.0
0.2
0.4
0.6
0.8
1.0
1.2
dot blot
R
e
l
a
t
i
v
e
 
5
h
m
C
l
e
v
e
l
+ −
− +
5m-dCMP
P < 0.01
MEF     iPS
dAMP
dTMP
dGMP
dCMP
5hm-
dCMP
Pi
5hmC/total C       1.4      2.7
(%) ±0.5    ±0.5
TLC
5
h
m
C
/
t
o
t
a
l
 
C
 
(
%
)
TLC
+ −
− +
LIF
RA
0
2
4
6
8 P < 0.05 P < 0.001
Tet1      Tet2       Tet3     Oct4
Figure 1. Tet1 and Tet2 Regulate 5hmC Levels in Mouse ESCs and Are Associated with the Pluripotent State
(A) Normalized transcript copy numbers of Tet1, Tet2, Tet3, and Oct4 in v6.5 mouse ESCs, determined using absolute standard curves of plasmid templates.
Gapdh transcript levels were used to estimate RNA content.
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Tet Enzymes Regulate ESC DifferentiationESCs also downregulated expression of the others because of
known cross-regulatory and cooperative interactions (Chew
et al., 2005; Loh et al., 2006).
Oct4 and Sox2 RNAi resulted in potent repression of Tet1 and
Tet2mRNA, to < 20% and 30% of control levels, respectively;
Tet3mRNAwas upregulated by4-fold and2-fold (Figure 2A).
Nanog RNAi had almost no effect on Tet1 and Tet3 while
reducing Tet2 expression moderately, to 60% of control. TLC
analysis at day 5 showed a marked loss of 5hmC at MspI sites
only in cells treated with Oct4 siRNA (Figure 2B).
Chromatin immunoprecipitation of biotin-tagged Oct4 from
ESCs stably expressing the BirA biotin ligase (Kim et al., 2008)
showed that Oct4 bound to sites located within conserved non-
coding sequence (CNS) regions of both the Tet1 and Tet2 genes
(Figures 2C–2H). In both cases, the sites resembled consensus
Oct4-Sox2 composite sites (Loh et al., 2006) and especially
the Oct4 portion of the site was strongly conserved between
human and mouse (Figures 2E and 2H). Oct4 binding sites
were not detected in other CNS regions of the Tet1 locus (Figures
S2C and S2D) or at two other predicted Oct4-Sox2 binding
elements in CNS regions at 140 kb and 200 kb 50 of the
Tet2 transcription start site. Althoughwe have not tested formally
whether these conserved Oct4-Sox2 composite sites function
as transcriptional regulatory elements, the combined data
suggest strongly that Tet1 and Tet2 are regulated by the Oct4-
Sox2 complex.
Tet1 Depletion Skews ESC Differentiation
We characterized gene expression in ES cells after siRNA-
mediated depletion of each of the three Tet proteins by quan-
titative RT-PCR. Tet mRNAs were maximally depleted by
3 days of transfection. Tet1 depletion had no effect on Tet2
mRNA expression and vice versa (Figure S1A). In contrast to
a previous report that Tet1 depletion led to diminished Nanog
mRNA and protein (Ito et al., 2010), Tet depletion did not affect
expression of the key pluripotency factors Oct4, Sox2 and
Nanog under our conditions for up to 5 days (Figure 3A), nor
was there a marked change in the undifferentiated appearance
of ESCs maintained in LIF (Figure S1D). Rather, Tet1 depletion
resulted in reproducible changes in expression of a panel of
lineage-specific markers within 3–5 days: there was a reproduc-
ible increase in expression of mRNAs encoding the trophecto-(B) Densitometric measurement of 50-hydroxymethyl-dCMP (5hm-dCMP) spot int
sites in the genome of ESCs after 5 days of siRNA transfection to deplete Tet1 and
5-methyl-dCMP (5m-dCMP), dCMP, and hm-dCMP. Error bars indicate SD of se
noted: C, control; T1, Tet1 SMARTpool; T2, Tet1 SMARTpool; T1+T2, combined
ure S1B. For ESC morphology and knockdown efficiency of Tet1 and Tet2, see
(C) Measurement of 5hmC levels in genomic DNA from transfected ESCs and H
control-transfected ESCs. HEK293T cells were transfected with either TET1-cata
cates from two experiments. In (B) and (C), p values derived from ANOVA with B
(D) Quantitative RT-PCRmeasurement ofOct4, Tet1, Tet2, and Tet3 transcript leve
presence of LIF, or differentiated by LIF withdrawal, or LIF withdrawal plus additio
three independent experiments.
(E) Measurement of hmC levels by TLC (left) and dot blot (right) in genomic DNA e
bars indicate SD of 3–5 replicates.
(F) Quantitative RT-PCR of Tet1, Tet2, and Tet3 transcript levels expressed relativ
viral transduction of Oct4, Sox2, Klf4, and c-Myc into iPSC clones. Error bars ind
(G)TLC (left) and hmCdot blot (right) analyses showing 5hmCdetected in iPSCs, b
ESCs. Error bars indicate SD of 3-5 replicates. p values in (E) and (G) are derived
Cderm markers Cdx2, Eomes, and Hand1, and a consistent
decrease in expression of the neuroectoderm markers Pax6
and Neurod1 and the Nodal antagonists Lefty1 and Lefty2 (Fig-
ure 3A, Figure S3A, and data not shown). Tet2 depletion had no
effect on trophectoderm, endoderm, and mesoderm markers
but consistently caused a small increase in expression of
Pax6, Neurod1, Lefty1, and Lefty2 (Figure 3A and Figure S3A),
whereas Tet3 knockdown caused a 50% repression of Lefty2
but otherwise had no effect on all other targets tested (Fig-
ure S3A and data not shown). Combined depletion of Tet1
and Tet2, shown above to decrease genomic 5hmC levels
almost to baseline (Figures 1B and 1C), had a similar but less
striking effect compared to Tet1 depletion alone (Figure 3A),
suggesting that Tet2 antagonizes the dominant effect of Tet1
at specific target genes.
To explore the effect of prolonged depletion of Tet1 on ESC
developmental potential, we generated ESC clones stably ex-
pressing shRNAs against Tet1 and Tet2. Two Tet1-depleted
clones, generated using Tet1 shRNA#2, showed >80%
decrease in Tet1 mRNA levels (Tet1-kd/shRNA#2.1 and
#2.2; Figure S3B, left); likewise, two Tet2-depleted clones,
generated using Tet2 siRNA sequences #1 and #3, showed
55% and 75% decrease in Tet2 mRNA levels, respectively
(Tet2-kd/shRNA#1 and #3; Figure S3B, right). Control clones
expressed an irrelevant shRNA (scramble [Scr]-kd) or shRNA
directed against GFP (GFP-kd). The clones could be propa-
gated serially on feeder cells in the absence of further selection
and were morphologically indistinguishable from parental and
control clones (Figure S3C). Growth proliferation rates of the
selected Tet-kd clones were similar to or slightly enhanced
compared to control clones (Figure S3D). Whole-genome
transcriptome analysis of stable Tet1-kd versus control ESC
clones largely confirmed the results from transient RNAi
transfections; gene ontology (GO) analysis of differentially ex-
pressed genes yielded many terms related to embryonic devel-
opment and cell-cycle regulation (Table S1). Possibly because
of incomplete knockdown, most gene-expression changes in
Tet1-kd ESCs were fairly modest (2- to 5-fold), and the cells
retained a genome-wide molecular signature typical of normal
ESCs.
We injected control shRNA and Tet-kd ES clones intramuscu-
larly into immunodeficient mice and observed teratomaensities detected on thin layer chromatography (TLC) analysis of enriched CpG
/or Tet2. Values are depicted as percentages of total dCMP species comprising
ven replicates from three independent experiments. siRNA treatments are de-
Tet1+Tet2 SMARTpool. A representative TLC autoradiogram is shown in Fig-
Figure S1.
EK293T based on antibody dot blot. Values are expressed relative to levels in
lytic domain (CD) or mock-transfected (). Error bars indicate SD of five repli-
onferroni’s multiple comparison test are denoted: *p < 0.05; ***p < 0.001.
ls inmouse ESCs cultured for 1–4 days on gelatinized (feeder-free) plates in the
n of 1 mMall-trans retinoic acid (RA). Data are represented as mean ± SEM from
xtracted from ESCs after 4 days of LIF withdrawal and treatment with RA. Error
e to levels in ESCs (marked as dotted lines), during reprogramming of MEFs by
icate SD (n = 3).
ut not in fibroblasts. hmC levels from dot blots are expressed relative to levels in
from t tests.
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Figure 2. Tet mRNA Levels Are Regulated by Oct4
(A) Quantitative RT-PCR of Tet1, Tet2, and Tet3 transcript levels in ESCs transfected for 5 days with Oct4, Sox2, and Nanog SMARTpool siRNA. Normalized
transcript levels are expressed relative to levels at the start of transfection. Data are mean ± SEM from three experiments. p values derived from ANOVA with
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Tet Enzymes Regulate ESC Differentiationformation. Within 4–7 weeks, control ESC lines formed well-dif-
ferentiated benign teratomas containing cells representative of
all three embryonic germ layers, whereas Tet1-kd clones formed
large aggressive tumors with massive internal hemorrhage
(Figures 3B–3D). Histologically, all three primary germ layer line-
ages could be found in Tet1-kd teratomas, but the relative contri-
butions of each lineage appeared altered compared to controls
(Figures 3C-D). Tet1-kd teratomas contained predominantly
immature glandular tissue with surrounding stromal cells, indic-
ative of definitive endoderm and mesoderm respectively; many
of the glandular cells contained nuclei in mitotic phases, sugges-
tive of a highly proliferative state (Figure 3E). There was consid-
erably less neuroectoderm in the teratoma and many regions
with necrotic tissue and blood (Figure 3D). A striking feature
was the presence of many giant cells with large nuclei, found
especially within and near the necrotic regions but also forming
distinct clusters (Figure 3F); many of these cells contained
glycogen-rich inclusion bodies, indicative of trophoblastic giant
cells of the extra-embryonic lineage (Figure 3G). These histolog-
ical features were independent of tumor size because sized-
matched control teratomas grown to full size were typically not
hemorrhagic, containedmore neural tissue, and rarely contained
any trophoblastic giant cells. Moreover, smaller Tet1-kd tera-
tomas obtained with injection of fewer cells (105 instead of 106)
still formed hemorrhagic tumors containing many giant cells
(Figures S3E and S3F).
Like Tet1-kd clones, Tet2-kd clones also formed large hemor-
rhagic teratomas that grewmore aggressively than controls (Fig-
ure 3H). Both Tet2-kd clones, generated by stable expression of
independent shRNA hairpins, displayed a similar phenotype of
hemorrhagy, although the phenotype was stronger in Tet2-kd/
shRNA#3-derived teratomas, correlating with stronger constitu-
tive Tet2 knockdown (Figure S3A, right). Despite the hemor-
rhagic appearance, there was more neuroectoderm contribution
in Tet2-kd teratomas, such that apart from the appearance of
regions with necrotic tissue, most cellular features still resem-
bled those of control teratomas (Figure 3I). Trophoblastic giant
cells were also less apparent in Tet2-kd compared to Tet1-kd
teratomas, appearing in clusters in only one oversized tumor har-
vested but otherwise barely represented in all other Tet2-kd
tumors (data not shown). We conclude that Tet1 loss-of-function
in ESCs results in developmental skewing toward endoderm/
mesoderm and trophoblast lineages, whereas Tet2 loss-of-
function maintains a tendency toward neuroectoderm.Bonferroni’s multiple comparison test are denoted: *p < 0.05; **p < 0.01; ***p < 0.0
see Figure S2.
(B) TLC analysis of genomic DNA purified frommouse ESCs differentiated byOct4
pendent experiments.
(C) Vista plot of sequence conservation between the human and mouse Tet1 gen
the Tet1 transcription start site and coding exon 1. Regions numbered 1 to 6 spa
regions in the Tet1 locus, see Figure S2C.
(D) Oct4 binding was detected as amplification from Oct4 biotin-mediated ChIP
formed in cells expressing only the biotin ligase (BirA). For a complete analysis o
(E) The mouse-human sequence alignment at the Tet1 site 5 showing a conserv
highlighted in red.
(F) Sequence conservation between the human and mouse Tet2 gene loci upstre
were probed.
(G) Oct4 binding was detected as amplification from Oct4 biotin-mediated ChIP
(H) The mouse-human sequence alignment at the Tet2 site 4 showing a conserv
CAltered Developmental Potential of Tet1-Depleted
ESCs: Skewing to Trophectoderm
The upregulation of transcripts encoding the trophectodermal
transcription factors Cdx2 and Eomes (Figure 3A), and the
appearance of trophoblastic giant cells in Tet1-kd tumors
(Figures 3F–3IG), suggested that Tet1 deficiencymight attenuate
the normal restriction of ESCs to embryonic tissues and permit
their transdifferentiation into extra-embryonic trophoblast deriv-
atives. Indeed, a previous report showed that when Tet1 siRNA
was injected together with a marker gene into mouse embryos
at the two-cell stage, the marked (presumably Tet1-depleted)
cells were moderately excluded from the inner cell mass (ICM)
and enriched in the trophectoderm (Ito et al., 2010).
To explore this phenotype further, we cultured control and
Tet1-kd clones on feeders in the presence of FGF4 and heparin,
but without exogenous LIF, a culture condition previously
described to favor the derivation of trophoblast stem (TS) cells
from the trophectoderm of blastocysts (Tanaka et al., 1998). In
these alternative ‘‘TS’’ culture conditions, Tet1 depletion did
not result in obvious morphological changes: both control
(scramble shRNA) and Tet1-kd ESCs formed dense undifferenti-
ated colonies that tended to be flatter with jagged edges, thus
showing some resemblance to true TS cells, which are flat with
a ridge-like periphery (Figure S4A). After 2 weeks in TS cell
culture conditions, we observed a robust and reproducible
induction of Elf5 transcripts in Tet1-kd clones (50- to 200-fold
increase in Elf5 mRNA over the low background expression
seen in control clones, approaching 10%–20% of the levels
observed in TS cells; Figure 4A). Elf5 lies downstream of the early
trophoblast lineage determinants Cdx2 and Eomes and was
recently described as a commitment marker for the tropho-
blastic fate (Ng et al., 2008). Moreover, whole-genome gene
set enrichment analysis of Tet1-kd clones compared to control
clones in TS conditions revealed significant enrichment (both
FDR q value and FWER p value of 0.02) of a core set of genes
defining trophectodermal cell differentiation, including Cdx2,
Eomes, and Tead4 (Figure S4B). Expression of intermediate
trophoblast (Tpbpa) or differentiated giant cell markers (PL1) in
Tet1-kd clones was not observed during the course of TS cell
culture, suggesting that the cells were being sustained in a
TS-like state without overt differentiation into trophoblasts. To
further investigate trophectoderm skewing, we cultured the
Tet1-kd/shRNA#2.1 ESC clone for 2 weeks in TS culture con-
ditions, picked three subclones, Tet1-kd/shRNA#2.1-sc1, .2,01. For ESCmorphology and knockdown efficiency ofOct4, Sox2, and Nanog,
RNAi. Values of 5hmC levels are mean ± SD of three replicates from two inde-
e loci upstream of the first coding exon, depicting CNS regions in the vicinity of
ced at 1 kb intervals were probed by ChIP PCR. For a diagram of all the CNS
samples from ESCs at the target sites depicted in (C). Control ChIP was per-
f Oct4 binding to all CNS regions in the Tet1 locus, see Figure S2D.
ed Oct4-Sox2 consensus element (boxed). The Oct4 consensus sequence is
am of the first coding exon. Regions numbered 1 to 5 spaced at 1 kb intervals
samples from ESCs at the target sites depicted in (F).
ed Oct4-Sox2 consensus element (boxed).
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Figure 3. Tet Depletion Selectively Affects
Cell LineageMarkers and SkewsESCDiffer-
entiation
(A) Effect of Tet1 (T1), Tet2 (T2), Tet3 (T3), or
combined Tet1+Tet2 (T1+T2) SMARTpool
siRNAs on the expression of pluripotency and
selected lineage marker genes, assessed after
5 days of transfection. C, non-targeting control
siRNA. Data are represented as mean ± SEM,
n = 3 to 4. *p < 0.05; **p < 0.01; ***p < 0.001 by
ANOVA with a post-hoc test for comparison to
control. See also Figure S3A.
(B) Enhanced growth and extensive hemorrhagy in
Tet1-kd tumors compared to GFP-kd controls.
Refer to Figure S3 for knockdown efficiency in
stable Tet-kd ESC clones.
(C) Gross histology of teratomas formed after
injection of control clones, revealed through low-
power images of hematoxylin/eosin (H&E)-stained
sections (left), showing high contribution of differ-
entiated neuronal tissue (pink). A higher power
image (right) shows mature epithelium with
squamous differentiation (arrowhead), terminally
differentiated neuronal tissue (block arrow), and
immature glandular tissue (white arrow).
(D) Low-power image of a Tet1-kd teratoma (from
Tet1-kd/shRNA#2.1), showing predominance of
immature glandular tissue (purple). A higher power
image (right) shows necrotic tissue with blood and
scattered giant cells (black arrow) and glandular
tissue (white arrow).
(E) Tet1-kd teratoma showing highly proliferative
glandular tissues. Inset: a cell undergoing mitosis
is marked with asterisk.
(F) Tet1-kd teratoma showing a cluster of tropho-
blastic giant cells (arrows).
(G) Periodic acid-Schiff staining of a serial section
from the Tet1-kd tumor shown in (F), showing
glycogen-rich granules (purple stain) in giant cells
(arrows).
(H) Hemorrhagy in Tet2-kd tumors compared to
scrambled-kd controls.
(I) Low-power image of H&E-stained Tet2-kd tera-
toma (from Tet2-kd/shRNA#3), showing areas of
fully differentiated neuronal tissue (pink) and glan-
dular tissue (purple). Inset, neuronal tissue.
Histology of Tet1-kd shown is representative of
tumors from Tet1-kd/shRNA#2 (each clone
#2.1 and #2.2 injected into two mice per experi-
ment) from three independent experiments per-
formed with two different strains of immunodefi-
cient mice. Each Tet2-kd clone was injected in
two mice per experiment in two independent
experiments.
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Tet Enzymes Regulate ESC Differentiationand .3 based on flattened TS-like morphology, and propagated
them in TS culture conditions. Quantitative RT-PCR analysis of
these subclones showed a dramatic induction of Cdx2, Eomes,
and Elf5 expression compared to control shRNA and parental
cell lines (Figure 4B); again, however, expression of these TE
markers in the subclones was only a fraction of levels in TS cells,
suggesting that the cells are propagating as an intermediate cell
type between the ESC and TS cell states.206 Cell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc.The association of Tet1 knockdown with Cdx2, Eomes, and
Elf5 activation suggested that Tet1 might function to repress tro-
phectoderm development during early embryogenesis. To test
this hypothesis, we injected GFP-labeled Tet1-kd ESC lines,
cultured either in ESC or TS cell conditions, into mouse blasto-
cysts and observed chimerism in mid-gestation (E10.5) embryos
by GFP fluorescence. Typically, ESCs injected into the ICM of
blastocysts contribute only to the developing embryo and not
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Figure 4. Tet1 Depletion in ESCs Predisposes Cells to Differentiate along a Trophoblastic Lineage
(A) Time-course of expression of Elf5 in control and Tet1-kd clones grown in TS conditions for 1–4 weeks. Data represent mean ± SEM of four independent exper-
iments.
(B) Expression of trophectodermmarkersCdx2, Eomes, and Elf5 in the Tet1-kd/shRNA#2 line and subclones cultured in TS cell conditions for 4 weeks compared
to parental cells in TS cell or ESC conditions. Normalized transcript levels in (B) and (C) are expressed relative to levels in TS cells (set as 100).
(C) Midgestation embryo chimerism of GFP-labeled control (scrambled shRNA) or Tet1-knockdown (Tet1-kd/shRNA#2) cells injected into blastocysts after
culture in ES or TS conditions. Brightfield (left) and whole-mount GFP fluorescence (right) images were taken at E10.5. e, embryo; ys, yolk sac; p, placenta.
(D) Scoring of GFP presence in embryos and placentas at midgestation.
(E) GFP antibody staining of placental section showing chimerism of a Tet1-kd subclone (sc3) from TS cell culture.
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Tet Enzymes Regulate ESC Differentiationto placental tissues (Beddington and Robertson, 1989), and this
was indeed observed with ESCs expressing a scrambled control
shRNA (Figure 4C). Tet1-kd ESCs from ESC cultures also chi-
merized the developing embryo, consistent with our data fromCteratomas that differentiation into the three primary germ layers
is not completely blocked; however, the contribution to embryos
appeared reduced and in rare cases, GFP+ cells could even
be detected in placental tissue (manifested as spots ofell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc. 207
Cell Stem Cell
Tet Enzymes Regulate ESC Differentiationextraembryonic GFP+ cells in one embryo, or as faint GFP+ cells
in another 2/35 embryos obtained from five uterine transfers)
(Figure 4D). When the same GFP-labeled ESCs were cultured
for 4 weeks in TS cell conditions, there was a marked reduction
in the ability of both control and Tet1-kd clones to chimerize the
embryos based on GFP fluorescence; this, in part, reflects
a technical shortcoming because of silencing of GFP observed
in prolonged TS culture conditions. However, injection of
a Tet1-kd clone or subclone from TS cell culture occasionally
produced embryos with bright aggregates of GFP-positive cells
in the placenta (Figure 4C). The presence of GFP+ cells in the
placenta was confirmed by immunohistochemical staining for
GFP (Figure 4E). In contrast, none of the control ESCs express-
ing control shRNA gave rise to any bright GFP-fluorescent cells
in the placenta, whether cultured under ESCs or TS conditions.
Together, these data suggest that a small subset of Tet1-kd
ESCs cultured in either ESCs or TS conditions are able to cross
an embryonic restriction barrier to colonize the placenta.
Altered Developmental Potential of Tet1-Depleted
ESCs: Skewing to Mesendoderm
Weaskedwhether the observed increase in the representation of
cells of the mesoderm and endoderm lineages in teratomas
formed from Tet1-kd ESCs (Figure 3D) could reflect decreased
expression of the Nodal antagonist Lefty (Figure 3A). Nodal
and Lefty are both members of the TGFb superfamily (Schier,
2009; Shen, 2007; Tabibzadeh and Hemmati-Brivanlou, 2006).
Nodal signals act asmorphogens and are essential for the induc-
tion of mesoderm and definitive endoderm in the gastrulation-
stage embryo when uncommitted epiblast cells move through
the primitive streak, a structure marked by expression of the
transcription factor Brachyury (Bry) (Tam and Loebel, 2007).
Mesoderm is induced from the posterior primitive streak in
response to Wnt or low levels of TGFb/Nodal/Activin signaling,
whereas definitive endoderm arises in response to high, sus-
tained Nodal/Activin signals from ‘‘mesendoderm’’ progenitors
in the anterior posterior streak that are marked by expression
of Foxa2 and Goosecoid. We postulated that Tet1 depletion,
by decreasing Lefty expression, would increase Nodal signals
and result in the mesoderm/endoderm skewing observed in
our teratoma assays.
To test this hypothesis, we used theCD4-Foxa2/GFP-Bry ESC
line (E14.1, 129/Ola) in which Brachyury and Foxa2 expression
are read out as expression of GFP and a cell-surface receptor,
human CD4, respectively (Gadue et al., 2006). If Tet1 depletion
in this cell line indeed led to mesoderm and/or endoderm skew-
ing, this would be apparent in ESC in vitro differentiation assays
as increased expression of Brachyury and/or Foxa2, respec-
tively. We depleted Tet1 in CD4-Foxa2/GFP-Bry ESCs using
two independent Tet1 siRNAs and then allowed the cells to
differentiate into embryoid bodies (EB) for 4 days. During the
last 2 days of differentiation, we supplemented some cultures
with graded concentrations of TGFb family member Activin A
(1, 5, or 25 ng/ml) as a positive control to stimulate mesoderm
and endoderm formation. Unlike Nodal, Activin is not inhibited
by Lefty (Chen and Shen, 2004). As expected, Tet1 transcripts
declined to50% of control levels by day 2 of EB formation (Fig-
ure 1D), but siRNA treatment decreased Tet1mRNA expression
even further (data not shown). Control siRNA-transfected ESCs208 Cell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc.remained CD4- and GFP-negative during EB differentiation,
but treatment with Tet1 siRNA (especially siRNA#2) led to the
emergence of subpopulations expressing CD4 and GFP indi-
cating strong expression of Foxa2 and low expression of Bra-
chyury, respectively (Figure 5A, top panels; Figure 5B). GFP-Bry
and CD4-Foxa2 expression were increased in Tet1 siRNA-
treated cells that were also exposed to low concentrations of
activin (5 ng/ml) (Figure 5A, middle panels; Figure 5B). Similarly,
when stable Tet1-kd ESC clones (v6.5 cell line) were subjected to
in vitro EB differentiation, we again observed induction of Foxa2
and Brachyury as measured by qRT-PCR (Figure 5C).
We examined Nodal/Activin signaling in whole-cell lysates of
control and Tet1-depleted EB at day 4 by western blotting (Fig-
ure 5D). In control-siRNA-treated cells, high doses of Activin A
(25 ng/ml) stimulated Smad2 phosphorylation, upregulation of
Eomes, and upregulation of Lefty (Figure 5D, lane 4; the Lefty
antiserum recognizes both Lefty 1 and Lefty 2; note the particu-
larly strong upregulation of high molecular weight forms of
Eomes.) These results are consistent with previous reports that
Eomes is a downstream target of Nodal/Activin signaling (Arnold
et al., 2008; Brennan et al., 2001) and that both Nodal itself and
the inhibitor Lefty are induced byNodal/Activin signals in positive
and negative autoregulatory feedback loops (Besser, 2004; Sai-
joh et al., 2000). Notably, Tet1-depleted ESCs also showed
increased Smad2 phosphorylation and increased Eomes
expression in the absence of activin (particularly striking in the
case of Tet1 siRNA#2, lane 9), suggesting that decreased levels
of Tet1 promote increased signaling in the TGFb pathway. These
effects of Tet1 depletion were potentiated by activin treatment
(lanes 7, 10, and 11). Interestingly, Tet1 depletion abolished
the activin-induced increase in Lefty expression.
Tet1DepletionHasComplex Effects onDNAMethylation
at Target Gene Promoters
Tet enzymes regulate DNA methylation by modifying 5mC and
have been proposed to promote DNA demethylation in multiple
ways (Tahiliani et al., 2009). By converting 5mC to 5hmC, Tet
proteins diminish DNA methylation. Moreover, because 5hmC
is not recognized by Dnmt1, its presence would promote passive
demethylation. Finally, 5hmC might be actively removed by
a DNA repair system and replaced by unmodified cytosine.
Consistent with these possibilities, the Nanog promoter has
been reported to become hypermethylated in ESCs depleted
of Tet1 (Ito et al., 2010). In contrast, however, we have shown
that Tet2 loss-of-function in myeloid tumors results in global
hypomethylation rather than localized hypermethylation at CpG
dinucleotides in the genome (Ko et al., 2010).
To investigate the relation of Tet1 depletion to changes in DNA
methylation, we examined the promoters of two Tet1-regulated
genes, Lefty1 and Elf5. The Lefty1 promoter is hypomethylated
in stem cells and hypermethylated in differentiated cells (Farthing
et al., 2008), whereas the Elf5 promoter is hypermethylated (and
repressed) in ESCs compared to TS cells (Ng et al., 2008). We
first examined DNA ‘‘methylation’’ at the Lefty1 promoter in
ESCs depleted of Tet1 by RNAi, using the bisulfite sequencing
technique, which does not distinguish 5mC and 5hmC (Huang
et al., 2010). Compared to control-treated cells in which the
locus was hypomethylated, Tet1-depleted ESCs showed an
increase in CpG ‘‘methylation’’ levels at specific regions of the
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Figure 5. RNAi Depletion of Tet1 in ESCs Skews Differentiation toward the Endoderm-Mesoderm Lineages In Vitro
(A) Expression of CD4 and GFP in CD4-Foxa2/GFP-Bry ESCs transfected with Tet1 siRNA and differentiated in serum-free media for 4 days to form EB. EB
cultures were reaggregated and treated with Activin A (Act) at the indicated concentrations at day 2. Numbers in quadrants denote percentage of gated cell
populations.
(B) Percentages of CD4-high andGFP-high cell populations in Day 4 EB after siRNA treatment. Three independent experiments are shown comparing control and
Tet1 siRNA#2 treatments.
(C) Quantitative RT-PCR analysis of Foxa2 andBrachyury in day 4 EB differentiated from Tet1-kd/shRNA#2 stable clones. Data aremean ± SEM of three clones in
each group, representative of two independent experiments.
(D) Western blot analysis of phospho-Smad2, total Smad2/3, Eomes, and Lefty in whole-cell lysates of day 4 EB.
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Tet Enzymes Regulate ESC Differentiation1.4 kb Lefty1 promoter region (Figure 6A), consistent with the
notion that Tet1 directly or indirectly regulates Lefty1 expression
by facilitating DNA demethylation. In contrast, the Elf5 promoter
was as highly ‘‘methylated’’ in Tet1-kd ESC subclones as in the
parental ESCs (Figure 6B), despite the fact that Elf5 transcripts
were more highly expressed (Figures 4A and 4B).CDISCUSSION
In this study, we report the functional roles of Tet proteins,
a newly-discovered family of DNA-modifying enzymes, in mouse
ESCs and iPSCs. We show that Tet1 and Tet2 are the key
enzymes responsible for the presence of 5hmC in mouse ESCsell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc. 209
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Figure 6. Tet1 Depletion Has Different Effects on DNA Methylation at Target Gene Promoters
(A) Bisulphite sequencing analysis of CpG methylation status at the Lefty1 promoter in ESCs transfected with control or Tet1 SMARTpool siRNA. The average
percent methylation at each CpG site is derived from sequencing of 20–24 clones.
(B) Bisulphite sequencing analysis of the Elf5 promoter in ESCs, TS cells, and various Tet1-kd ES clones in TS culture condition. The percent methylation at each
CpG site is derived from sequencing of 10–12 clones. Three Tet1-kd/shRNA#2.1 subclones were analyzed, and errors bars are mean ± SEM.
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Tet Enzymes Regulate ESC Differentiationand iPSCs, that their expression is regulated by Oct4, and that
their activity (as judged by 5hmC levels) correlates closely with
the pluripotent state. In contrast to a previous report (Ito et al.,
2010), acute RNAi-mediated depletion of Tet1 alone, or both
Tet1 and Tet2, did not in our hands cause overt ESC differentia-
tion, diminish ESC proliferation, or affect expression of the key
pluripotency factorsOct4, Sox2, andNanog. Rather, Tet1 deple-
tion correlated with decreased expression of the Nodal antago-
nists Lefty1 and Lefty 2, increased expression of the mesoderm/
endoderm transcription factors Brachyury and Foxa2, and
increased expression of the trophoectoderm transcription
factors Cdx2, Eomes, and Elf5. While we have not yet estab-
lished whether these genes are direct or indirect targets of
Tet1, it is notable that each lies at a ‘‘crossroads’’ of cell-fate
determination during embryonic development (Ng et al., 2008;
Tabibzadeh and Hemmati-Brivanlou, 2006).
Tet enzymes are downstream targets of the transcription
factor network that maintains ESC pluripotency. Oct4 depletion
led to rapid ESC differentiation, a parallel strong decrease in Tet1
and Tet2 mRNA expression, and an increase in Tet3 mRNA
expression. Sox2 RNAi had a similar but less dramatic effect.
BIO-ChIP assays showed Oct4 binding to both the Tet1 and
Tet2 loci at composite Oct4/Sox2 sites, suggesting strongly
that Tet1 and Tet2 are directly regulated by the cooperative
Oct4/Sox2 complex. A previous genome-wide ChIP-seq anal-210 Cell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc.ysis showed Oct4 binding to the Tet2 locus (Chen et al., 2008);
however, neither this nor earlier studies (Boyer et al., 2005; Kim
et al., 2008; Loh et al., 2006) identified Tet1 or Tet3 asOct4 target
genes, possibly because the signals did not reach statistical
significance. We note that the mild effect of Nanog depletion
on Tet2 gene expression may be indirect, through the ability of
Nanog to regulate Oct4 and Sox2 (Loh et al., 2006).
Our studies highlight a strong correlation between Tet1 and
Tet2 expression and the pluripotent state. Stimuli that induced
ESC differentiation—LIF withdrawal, RA addition, and Oct4
RNAi—caused loss of Tet1 and Tet2 expression and a parallel
loss of genomic 5hmC. A previous kinetic analysis of gene
expression in ESCs undergoing RA-induced differentiation also
identified Tet1 (D10Ertd17e) as one of 65 rapidly downregulated
candidate genes (Ivanova et al., 2006); however, Tet1 was not
characterized further in this study, because—as also observed
in our hands—shRNA-mediated knockdown of Tet1 did not
dramatically affect morphology or alkaline phosphatase activity
in ESCs. Conversely, reprogramming of fibroblasts to iPSCs
was associated with increases in Tet1, Tet2, and 5hmC, and
combined depletion of both Tet1 and Tet2 during early reprog-
ramming by doxycycline-inducible RNAi reduced the number
of iPSC colonies by about 50% (K.P.K., C.A.S., G.M., and A.R.,
unpublished data). A formal demonstration of the role of
Tet enzymes in iPSC reprogramming will require the use of
Cell Stem Cell
Tet Enzymes Regulate ESC Differentiationrobust overexpression systems as well as fibroblasts from Tet-
deficient mice.
At several genes examined (e.g., Cdx2, Eomes, Lefty, Pax6),
the effects of Tet1 depletion were dominant over an often mildly
opposing effect of Tet2 depletion. Since both enzymes catalyze
the conversion of 5mC to 5hmC, it is likely that they are recruited
to disparate (possibly overlapping) sets of target genes and in
turn recruit distinct transcriptional regulatory complexes through
their divergent N-terminal regions. Notably, TET2 and 5hmC are
also expressed, albeit at lower levels, in other tissues and cell
types including hematopoietic stem cells (HSCs) (Delhommeau
et al., 2009; Ito et al., 2010; Ko et al., 2010); thus, TET2may regu-
late cell-fate decisions in adult stem/precursor cells as well.
Indeed, RNAi-mediated depletion of Tet2 in early hematopoietic
precursors resulted in skewed differentiation, with an enhanced
propensity to commit to the myeloid lineage in response to
appropriate cytokines in vitro (Ko et al., 2010).
The gene expression changes observed in ESCs in response
to acute Tet1 depletion were consistent with the developmental
effects observed in teratoma assays in vivo and embryoid body
formation in vitro. Teratomas formed by Tet1 and Tet2-kd ESCs
contained cells from all three germ layers, albeit with altered rela-
tive contributions compared to control ESCs, indicating that Tet1
and Tet2-kd ESCs retained pluripotency. Tet1-kd teratomas
contained a high proportion of cells of the definitive endoderm
and mesoderm lineages; cells of the neuroectoderm lineage
were considerably fewer. Tet2-kd clones also formed large
hemorrhagic teratomas but with greater contribution from neuro-
ectoderm. These features are consistent with the role of Lefty
proteins (positively regulated by Tet1, mildly repressed by
Tet2) as inhibitors of the TGF-b family member Nodal. Down-
stream of Activin/Nodal receptors, moderate and strong induc-
tive signals mediated by Smad2/3 support differentiation into
mesoderm and definitive endoderm lineages marked by Bra-
chyury and Foxa2 expression, respectively (Gadue et al., 2006;
Kubo et al., 2004). Thus, diminished Lefty expression associated
with Tet1 depletion would be expected to increase Smad
signaling under conditions where the Nodal pathway was active;
increase expression of the downstream target of Nodal
signaling, Eomes; increase Brachyury and Foxa2 expression in
differentiation assays in vitro; and skew development toward
mesoderm/endoderm lineages in vivo, exactly as actually
observed. Reciprocally, the slight increase in Lefty expression
caused by Tet2 depletion would be expected to decrease
Smad signaling and decrease the constraint on neuroectoderm
gene expression. Although downregulation of Pax6 upon Tet1
depletion can also skew differentiation of mesendoderm by
causing loss of neural progenitors, we did not observe any
perceptible loss of Pax6 and NeuroD1 proteins when Tet1-
depleted ESCs were differentiated for 4 days into embryoid
bodies (data not shown). Thus, small changes in gene expres-
sion in Tet1-kd ESCs can be amplified into major changes in
the strength of Nodal/Activin signaling, resulting in pronounced
mesendoderm skewing during ESC differentiation.
Tet1-kd teratomas also showed a marked increase in the
number of trophoblastic giant cells, especially amidst hemor-
rhagic and necrotic tissue. Furthermore, Tet1-kd ESCs chimer-
ized placental tissue ectopically in midgestation stage embryos
following blastocyst injection, albeit at low frequency. Again,Cthis tendency was also apparent in vitro: Tet1-kd ESCs showed
only a small increase in expression of the trophectoderm
markers Cdx2 and Eomes and did not express Elf5, but
increased the expression of all three genes upon switching to
TS culture conditions that promote derivation of trophoblast
stem cells. Thus, an induction signal for differentiation (LIF with-
drawal and supplementation with Fgf4 and heparin) accentuates
the effect of Tet1 deficiency on lineage commitment markers.
Our data suggest a complex relation between Tet proteins and
DNA methylation. Tet1 depletion resulted in increased DNA
methylation at the Lefty1 promoter in parallel with decreased
expression of Lefty1 mRNA and protein. These data are consis-
tent with the possibility that Tet1 promotes hydroxymethylation
of the Lefty1 promoter, facilitating demethylation and, hence,
promoting Lefty1 transcription. This hypothesis is clearly inade-
quate in the case of Elf5, however. The Elf5 promoter is normally
silenced in ESCs by DNAmethylation, and its demethylation and
activation are required for ESCs to differentiate into trophoblast
derivatives (Ng et al., 2008). In contrast, we find that Tet1 deple-
tion correlated with increased Elf5 expression and trophecto-
derm skewing even though ESCs, ESCs cultured under TS
conditions, and Tet1-kd ESCs cultured under TS conditions
show similar hypermethylation at the Elf5 promoter, compared
to the hypomethylation observed in TS cells. Since conventional
bisulfite sequencing does not distinguish 5mCand 5hmC (Huang
et al., 2010; Jin et al., 2010; Nestor et al., 2010), we have not
formally ruled out the possibility that 5hmC is present at a subset
of CpG sites at the Elf5 promoter. Although further studies are
required to ascertain whether Tet1 binds directly to Lefty, Elf5,
or other target genes, it is clear that the effect of Tet1 on DNA
methylation and gene expression in ESCs cannot be explained
by the simple postulate that 5hmC is an intermediate in a DNA
demethylation pathway. Because Elf5 is located downstream
of the trophoblast differentiation cascade and is induced by
the early trophoblast lineage determinants Cdx2 and Eomes,
one possibility is that Tet1 depletion increases Elf5 expression
indirectly, through upregulation of Cdx2 and Eomes.
In summary, our studies identify Tet proteins as key regulators
of early embryonic differentiation. Our data suggest that these
enzymes do not act alone but, rather, operate in coordination
with developmental signals to regulate lineage determination at
decision points that are critical for early lineage commitment.
We propose that Tet1 functions downstream of Oct4 in the first
lineage split between inner cell mass and trophectoderm to
constrain Elf5 expression in the inner cell mass; later in develop-
ment,when theepiblast differentiates into the three somatic germ
layers, Tet1 coordinates the canalization of developmental
pathways by regulating Lefty (Figure S5). An understanding of
the roles of Tet proteins and the epigenetic mark, 5hmC, in ESC
function and embryonic development will require analysis of
Tet-disrupted mice and the genome-wide localization of 5hmC.
EXPERIMENTAL PROCEDURES
Oct4 Binding Site Bioinformatics and Chromatin
Immunoprecipitation
Alignments between the mouse and human Tet1 gene loci were performed on
the Vista Browser (http://pipeline.lbl.gov/cgi-bin/gateway2) to include all
intervening untranscribed regions between neighboring genes. Putative
Oct4-Sox2 consensus sites were detected by the EMBOSS programell Stem Cell 8, 200–213, February 4, 2011 ª2011 Elsevier Inc. 211
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Tet Enzymes Regulate ESC Differentiation(http://emboss.sourceforge.net/docs/adminguide/node6.html) using the fuzz-
nuc command line to detect the pattern ‘‘C[AT]TTGTN(0,5)ATGCAAAT’’ toler-
ating amismatch of two bases. Predicted siteswithin CNS regions weremanu-
ally assessed. PCR primers were designed to probe CNS regions at 1 kb
intervals and are shown in Supplementary Information. ChIP reactions were
performed as previously described (Rao et al., 2010). Samples were analyzed
under similar conditions, and fold enrichments were calculated by comparing
ChIP samples to genomic DNA controls after normalizing to GAPDH.
Teratoma Formation
Tumors and teratomas were obtained by intramuscular injection of 1 3 106
ESCs into each quadripcep of either NOD/SCID (Charles River Laboratories,
Wilmington, MA) or Rag2/;gC/ mice with similar results. Specimens
were collectedwhen tumors exceeded 2.0 cm in diameter andwere fixed over-
night in 4% paraformaldehyde. Paraffin sections and staining were performed
by the Specialized Rodent Histopathology Services at Brigham and Women’s
Hospital. Animal handling and maintenance were performed in accordance
with institutional guidelines.
Chimera Generation
Fifteen ES or ES-TS cells labeled with GFP by lentiviral vectors were injected
into mouse blastocysts and implanted by uterus transfer into pseudopregnant
foster mothers using standard methods. Pregnant mice were sacrificed at day
E10.5, and whole embryos were photographed with an inverted fluorescent
microscope. Specimenswere fixed overnight in 10% formalin, mounted in His-
toGel (Richard-Allan Scientific, MI), and stored in 80% ethanol. Paraffin
sections and anti-GFP staining were performed at the Specialized Rodent
Histopathology Services, Brigham and Women’s Hospital.
ESC Serum-free Embryoid Body Differentiation
CD4-Foxa2/GFP-Bry ESCs were maintained in serum-containing media with
feeder cells before adaptation on feeder-free gelatin-coated wells in serum-
free culture media (Invitrogen, Carlsbad, CA unless otherwise indicated) con-
sisting of Knockout DMEM/F12 supplemented with 0.53 of both N2 and B27,
penicillin/streptomycin, 0.05% BSA, LIF (1% conditioned medium), human
BMP4 (10 ng/ml; R&DSystems,Minneapolis, MN), and 1.53 104M 1-thiogly-
cerol (Sigma, St. Louis, MO) as previously described (Gadue et al., 2006).
ESCs were adapted for two passages in serum/feeder-free culture and trans-
fected at 1.5 3 105 cells/ml for 2 days with 50 nM siRNA using Lipofectamine
RNAiMAX according to manufacturer’s instructions. To induce embryoid body
(EB) differentiation (day 0), cells were dissociated by TrypLE Express and
cultured at 1 3 105 cells/ ml in serum-free differentiation media consisting of
75% Iscove’s modified Dulbecco’s medium and 25% Ham’s F12 media sup-
plemented with 0.53 of both N2 and B27 (without retinoic acid), 0.05% BSA,
50 mg/ml ascorbic acid (Sigma), and 4.53 104 M 1-thioglycerol. At day 2, the
EBs were dissociated with TrypLE Express and reaggregated in serum-free
differentiation media with the addition of human activin A (R & D systems). Re-
transfections of siRNA were performed at days 0 and 2 of EB aggregation. At
day 4, EBs generated were dissociated by incubation with trypsin and stained
with anti-human CD4-phycoerythrin (BioLegend, San Diego, CA). The cells
were analyzed by a FacsCalibur flow cytometer (Becton Dickinson, Franklin
Lakes, NJ) and data processed with FlowJo software (TreeS Star, Ashland,
OR). Note that Tet1 siRNA#1 and #2 correspond to Tet1 siRNA 1.1 and 1.2,
respectively, in Figure S1A. For unknown reasons, Tet1 siRNA#1 was less
effective than siRNA#2 in CD4-Foxa2/GFP-Bry ESCs, although in v6.5
ESCs, the two siRNAs were equivalent (see Figure S1A).
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